MedTrace Logo

Superovulation And Urinary Concentration of Estrone

NCT05493202 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2022-08-09

No results posted yet for this study

Summary

To determine if measurement of urinary estrone glucuronide concentrations with an at-home device is correlated with superovulatory response during gonadotropin stimulated IVF cycles.

Conditions

  • in Vitro Fertilization
  • Hormone Testing

Interventions

DEVICE

Mira Fertility Tracker

Non-interventional: observational, documenting urine E3G levels during gonadotropin stimulation.

Sponsors & Collaborators

  • Quanovate Tech Inc.

    collaborator INDUSTRY

  • Olive Fertility Centre

    lead OTHER

Eligibility

Min Age
21 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-20
Primary Completion
2022-06-13
Completion
2022-07-30
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05493202 on ClinicalTrials.gov